Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America

Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America

Background: Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation antihistamines as the cornerstone in therapy for chronic urticaria (C...

Full description

Bibliographic Details
Main Authors: Ivan Cherrez-Ojeda, Marcus Maurer, Jonathan A. Bernstein, Emanuel Vanegas, Miguel Felix, German D. Ramon, Luis Felipe Ensina, José Ignacio Larco Sousa, Edgar Emilio Matos Benavides, R. Cardona Villa, P. Latour Staffeld, Blanca María Morfin-Maciel, Jose Mori, Paul Wilches C, Valeria L. Mata, Annia Cherrez
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:World Allergy Organization Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455119300985

Internet

http://www.sciencedirect.com/science/article/pii/S1939455119300985

Similar Items